Clinical Trial Update: TroVax Renal Immunotherapy Survival Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update for TroVax renal immunotherapy in clear cell renal carcinoma; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Carcinoma

Drugs mentioned

• TroVax

Snippet

Sponsor: Oxford BioMedica | Conditions: Clear Cell Renal Carcinoma | Phase 3 | Status: COMPLETED